Risk of lung injury with immune checkpoint inhibitors after talc pleurodesis: A retrospective study. Tanaka S, Nozaki K, Watanabe S, Yanagimura N, et al. Lung Cancer 2025;204:108590.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tanaka S, Nozaki K, Watanabe S, Yanagimura N, et al. Risk of lung injury with immune checkpoint inhibitors after talc pleurodesis: A retrospective study. Lung Cancer 2025;204:108590.
PMID: 40412103